| Hasten Biopharmaceutic (Switzerland) AG - Hanarbe 40 mg, Tabletten | | 69936 | | 02 | | Hanarbe 40 mg | | Tabletten | | C09CA09 | | | | 08.08.2024 | | |
| | Composition | | azilsartanum medoxomilum 40 mg ut azilsartanum medoxomilum kalicum 42.68 mg, mannitolum, acidum fumaricum, natrii hydroxidum, hydroxypropylcellulosum, carmellosum natricum conexum, cellulosum microcristallinum, magnesii stearas, pro compresso, natrium 1.60 mg. | | Packungsbestandteile | | Comprimés | | | | Principe actif | Concentr. |
|---|
| | 40 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| | | | | | | | | | | | | | | | Mannitol | | | Sodium Hydroxide | | | Sodium | 1.6 mg | | | |
|
| |
|
